Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00147693 |
Recruitment Status
:
Completed
First Posted
: September 7, 2005
Last Update Posted
: October 1, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The objective is to ascertain the potential efficiency of a systematic care programme for caregivers of dementia patients. The research questions are:
- What are the costs and benefits of the Systematic Care Programme - Dementia (SCP-Dementia), as compared with usual care?
- What are the effects on the quality of life of patients and informal caregivers (spouse, relative), as compared with usual care?
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dementia, Vascular Dementia Alzheimer Disease Lewy Body Disease | Behavioral: Diagnosis of caregivers' problems Behavioral: Professional service: treatment of problems by counseling or practical support | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 304 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Diagnostic |
Official Title: | Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach? |
Study Start Date : | June 2005 |
Actual Primary Completion Date : | February 2006 |
Actual Study Completion Date : | February 2006 |
- Patients admissions to nursing homes or residential homes. This outcome is the most important input for the estimation of cost differences between the intervention group and controls. [ Time Frame: after one year follow-up period ]
- Secondary outcome for cost estimation is patient and caregiver related costs estimated by "Resource Utilisation in Dementia" (RUD), including time spent on caregiving, use of health care services by caregivers and patients and additional productivity.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Pairs of patients and their informal caregivers visiting the ambulatory mental health care service for the first time and treated by the professionals participating in the study
Exclusion Criteria:
- Patients and caregivers not mastering the Dutch language

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00147693
Netherlands | |
Radboud University Nijmegen Medical Centre | |
Nijmegen, Netherlands |
Principal Investigator: | Myrra M Vernooij-Dassen, PhD | Coordinator Alzheimer Centre UMC Nijmegen |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Prof.dr. M. Vernooij-Dassen, Scientific Institute for Quality of Healthcare (IQ Healthcare) and Alzheimer Centre Radboud University, Radboud University Nijmegen Medical Centre |
ClinicalTrials.gov Identifier: | NCT00147693 History of Changes |
Other Study ID Numbers: |
SCAD ZonMw grant no 945-04-152 |
First Posted: | September 7, 2005 Key Record Dates |
Last Update Posted: | October 1, 2008 |
Last Verified: | September 2008 |
Keywords provided by Radboud University:
Dementia Alzheimer Disease Lewy-Body Cost* Community (dwelling) |
Caregiver(s) Institutionalization Quality of life Randomized Control Trail Vascular dementia |
Additional relevant MeSH terms:
Dementia Dementia, Vascular Alzheimer Disease Lewy Body Disease Brain Diseases Central Nervous System Diseases Nervous System Diseases Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders |
Parkinsonian Disorders Basal Ganglia Diseases Movement Disorders Cerebrovascular Disorders Intracranial Arteriosclerosis Intracranial Arterial Diseases Leukoencephalopathies Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Cardiovascular Diseases |